Anthem, Inc. Completes Acquisition of Aspire Health
June 18 2018 - 11:00AM
Business Wire
Anthem, Inc. (NYSE:ANTM) announced today the completion of its
acquisition of Aspire Health, the nation’s largest provider of
non-hospice, community-based palliative care for people facing a
serious illness.
“Anthem is focused on leading the industry by offering
innovative, integrated clinical care models that help to transform
how we deliver care, enhance quality and improve outcomes,” said
Gail K. Boudreaux, President and CEO, Anthem. “With the addition of
Aspire, we are able to expand our capabilities and serve a broader
set of consumers in the home and other settings outside of the
hospital, while further deepening our relationships within the
healthcare community. The addition of Aspire to Anthem’s other
clinical care services, such as CareMore and AIM, will provide
tremendous benefit to our consumers, customers, health plan and
provider partners as well as future growth opportunities for our
company.”
Aspire Health offers specialized medical care focused on
addressing a patient’s specific symptoms, pain, and stress; and
improving quality of life for both patients and their families.
Working together with a patient’s medical team, Aspire’s clinicians
develop an integrated care plan to help manage symptoms such as
pain, shortness of breath, fatigue, nausea, loss of appetite,
difficulty sleeping and depression. The company also offers 24/7
support to patients, including nurse practitioner home visits.
Aspire Health will operate as a wholly-owned subsidiary of
Anthem, and its associates will join Anthem’s Diversified Business
Group. Financial terms of the transaction were not disclosed, and
the transaction is expected to be neutral to earnings in 2018 and
accretive to earnings in 2019.
About Anthem, Inc.
Anthem is working to transform health care with trusted and
caring solutions. Our health plan companies deliver quality
products and services that give their members access to the care
they need. With over 74 million people served by its affiliated
companies, including nearly 40 million within its family of health
plans, Anthem is one of the nation’s leading health benefits
companies. For more information about Anthem’s family of companies,
please visit www.antheminc.com/companies.
Forward-Looking Statements
This document contains “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements reflect our views about future events
and financial performance and are generally not historical facts.
Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,”
“anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan”
and similar expressions are intended to identify forward-looking
statements. These statements include, but are not limited to:
financial projections and estimates and their underlying
assumptions; statements regarding plans, objectives and
expectations with respect to future operations, products and
services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of
which are difficult to predict and generally beyond our control,
that could cause actual results to differ materially from those
expressed in, or implied or projected by, the forward-looking
statements. You are cautioned not to place undue reliance on these
forward-looking statements that speak only as of the date hereof.
You are also urged to carefully review and consider the various
risks and other disclosures discussed in our reports filed with the
U.S. Securities and Exchange Commission from time to time, which
attempt to advise interested parties of the factors that affect our
business. Except to the extent otherwise required by federal
securities laws, we do not undertake any obligation to republish
revised forward-looking statements to reflect events or
circumstances after the date hereof. These risks and uncertainties
include, but are not limited to: the impact of federal and state
regulation, including ongoing changes in the Patient Protection and
Affordable Care Act and the Health Care and Education
Reconciliation Act of 2010, as amended, or collectively the ACA;
trends in healthcare costs and utilization rates; our ability to
contract with providers on cost-effective and competitive terms;
our ability to secure sufficient premium rates including regulatory
approval for and implementation of such rates; reduced enrollment;
risks and uncertainties regarding Medicare and Medicaid programs,
including those related to non-compliance with the complex
regulations imposed thereon, our ability to maintain and achieve
improvement in Centers for Medicare and Medicaid Services, or CMS,
Star ratings and other quality scores and funding risks with
respect to revenue received from participation therein; competitive
pressures, including competitor pricing, which could affect our
ability to maintain or increase our market share; a negative change
in our healthcare product mix; our ability to adapt to changes in
the industry and develop and implement strategic growth
opportunities; costs and other liabilities associated with
litigation, government investigations, audits or reviews; the
ultimate outcome of litigation between Cigna Corporation, or Cigna,
and us related to the merger agreement between the parties,
including our claim for damages against Cigna, Cigna’s claim for
payment of a termination fee and other damages against us, and the
potential for such litigation to cause us to incur substantial
costs, materially distract management and negatively impact our
reputation and financial positions; medical malpractice or
professional liability claims or other risks related to healthcare
services provided by our subsidiaries; possible restrictions in the
payment of dividends by our subsidiaries and increases in required
minimum levels of capital; the potential negative effect from our
substantial amount of outstanding indebtedness; a downgrade in our
financial strength ratings; the effects of any negative publicity
related to the health benefits industry in general or us in
particular; unauthorized disclosure of member or employee sensitive
or confidential information, including the impact and outcome of
any investigations, inquiries, claims and litigation related
thereto; failure to effectively maintain and modernize our
information systems; non-compliance by any party with the Express
Scripts, Inc. pharmacy benefit management services agreement, which
could result in financial penalties, our inability to meet customer
demands, and sanctions imposed by governmental entities, including
CMS; state guaranty fund assessments for insolvent insurers; events
that may negatively affect our licenses with the Blue Cross and
Blue Shield Association; regional concentrations of our business
and future public health epidemics and catastrophes; general risks
associated with mergers, acquisitions and strategic alliances; our
ability to repurchase shares of our common stock and pay dividends
on our common stock due to the adequacy of our cash flow and
earnings and other considerations; possible impairment of the value
of our intangible assets if future results do not adequately
support goodwill and other intangible assets; changes in economic
and market conditions, as well as regulations that may negatively
affect our liquidity and investment portfolios; changes in U.S. tax
laws; intense competition to attract and retain employees; various
laws and provisions in our governing documents that may prevent or
discourage takeovers and business combinations; and general
economic downturns.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180618005754/en/
Anthem, Inc.Investor RelationsChris Rigg,
317-488-6887Chris.rigg@anthem.comorMediaJill Becher,
414-234-1573jill.becher@anthem.com
Anthem (NYSE:ANTM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anthem (NYSE:ANTM)
Historical Stock Chart
From Apr 2023 to Apr 2024